Michael Michael

机构：Peter MacCallum Cancer Centre · ORCID：0000-0002-0593-2662

发表论文 298 篇 · 总被引 7335 次 · h-index 45

代表论文

• Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers (2025 · JAMA Oncology · 被引 18)
• Safety and efficacy of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in high-grade neuroendocrine neoplasms. (2025 · Journal of Clinical Oncology · 被引 9)
• Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice (2025 · EClinicalMedicine · 被引 7)
• Pharmacogenetic‐guided dosing for fluoropyrimidine ( DPYD ) and irinotecan ( UGT1A1*28 ) chemotherapies for patients with cancer ( PACIFIC ‐ PGx ): A multicenter clinical trial (2024 · Clinical and Translational Science · 被引 7)
• Aligning kidney function assessment in patients with cancer to global practices in internal medicine (2025 · EClinicalMedicine · 被引 6)
• Feasibility and population exposure of 5‐fluorouracil using therapeutic drug monitoring (PREDICT‐5FU): A multicentre clinical trial (2025 · British Journal of Clinical Pharmacology · 被引 6)